Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis

PURPOSE: To investigate whether the addition of fluorouracil to docetaxel and cisplatin induction chemotherapy (IC) can truly improve the prognosis of patients with locoregionally advanced nasopharyngeal carcinoma (NPC). METHODS: A total of 801 patients newly diagnosed with non‐metastatic locoregion...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Hao‐Yun, Zhan, Ze‐Jiang, Qiu, Wen‐Ze, Liao, Kai, Yuan, Ya‐Wei, Zheng, Rong‐Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291171/
https://www.ncbi.nlm.nih.gov/pubmed/33945215
http://dx.doi.org/10.1111/ajco.13565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291171/
https://www.ncbi.nlm.nih.gov/pubmed/33945215
http://dx.doi.org/10.1111/ajco.13565

Ejemplares similares